Welcome to Community Sign in | Join | Help

New Hybrid Aspirin called "NOSH Aspirin" developed to prevent and fight Cancer.

Online Health Expert Cancer News Flash: Feb. 29, 2012  ACS Medicinal Chemistry Letters - In a National Cancer Institute funded research, scientists have developed and tested a Novel Hybrid "NOSH Aspirin" (Nitric Oxide and Hydrogen Sulfide releasing Aspirin) to be highly effective in inhibiting the growth of Breast, Colon, Pancreas, Lung, Prostate, and some Leukemia cells in experiments.


Nitric Oxide helps dilate the blood vessels and prevents the GI bleeding side effects of regular Aspirin and the Hydrogen Sulfide is a potent anti-inflammatory agent which greatly enhance the anti-cancer properties of the Novel NOSH Aspirin making it highly effective in preventing and fighting cancer in experiments.


The NOSH Aspirin was reported to be 100,000 times more potent than regular Aspirin against Cancer cell growth and did not damage normal cells.


Further Reading and Sources:

Link 1

Link 2


Thank you for updating your Medical Knowledge at Online Health Expert.


Sincerely,
Dr. Harish Malik.

Published Monday, March 12, 2012 8:28 AM by HealthExpert
Filed Under:

Comments

Anonymous comments are disabled